HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Selective motor control of the lower extremities in children with cerebral palsy: inter-rater reliability of two tests.

AbstractPURPOSE:
The purpose of this study was to examine the inter-rater reliability of two tests measuring selective motor control (SMC) of the lower extremities in children with cerebral palsy (CP).
METHODS:
Two testers independently assessed 21 children (13 boys, eight girls; mean age 6 years 5 months, SD 12 months) with spastic CP (14 unilateral and seven bilateral) using the Boyd and Graham SMC test (with an existing protocol) and the modified Trost SMC test (with a newly developed protocol). Inter-rater reliability was analysed using Cohen's Kappa.
RESULTS:
For the Boyd and Graham SMC test for ankle dorsiflexion, Kappa was 0.55 (95% CI = 0.36-0.74). For the modified Trost SMC test for ankle dorsiflexion, knee extension, hip abduction and hip flexion, Kappas were 0.65 (0.47-0.84), 0.69 (0.49-0.88), 0.57 (0.37-0.78) and 0.71 (0.51-0.91), respectively.
CONCLUSION:
The SMC tests showed moderate (Boyd and Graham SMC test) to good (modified Trost SMC test) inter-rater reliability.
AuthorsDirk-Wouter Smits, Annerieke C van Groenestijn, Marjolijn Ketelaar, Vanessa A Scholtes, Jules G Becher, Jan Willem Gorter
JournalDevelopmental neurorehabilitation (Dev Neurorehabil) Vol. 13 Issue 4 Pg. 258-65 ( 2010) ISSN: 1751-8431 [Electronic] England
PMID20629592 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Topics
  • Cerebral Palsy (diagnosis, physiopathology)
  • Child
  • Child, Preschool
  • Female
  • Humans
  • Lower Extremity (physiopathology)
  • Male
  • Movement (physiology)
  • Muscle, Skeletal (physiopathology)
  • Reproducibility of Results
  • Severity of Illness Index

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: